Position in NVO
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$753,281
+$152,419 QoQ
Shares Held
15,713
-3.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.24%
of 13F equity value
Holder Rank
#592
of 1,348 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026LOM Asset Management Ltd holds $11,059,224 across 8 Drug Manufacturers - General names. NVO ranks #7 (6.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
2,215 | $2,656,737 | |
| 2 | JNJ |
Johnson & Johnson
|
9,610 | $2,440,651 | |
| 3 | ABBV |
AbbVie Inc.
|
7,594 | $1,910,954 | |
| 4 | GSK |
GSK plc
|
22,268 | $1,167,288 | |
| 5 | MRK |
Merck & Co., Inc.
|
8,021 | $1,030,698 | |
| 6 | AMGN |
Amgen Inc
|
2,725 | $986,777 | |
| 7 | NVO |
Novo Nordisk A S
This page
|
15,713 | $753,281 | |
| 8 | NVS |
Novartis AG
|
720 | $112,838 |
All Filings in NVO
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $753,281 | 15,713 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $600,862 | 16,350 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $836,976 | 16,450 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $915,030 | 16,490 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $73,506 | 1,065 | Shares | Sole | 2025-08-07 | |
| No filing history on record for this holder in this stock. | ||||||